Cargando…

Regulation of Ebola virus VP40 matrix protein by SUMO

The matrix protein of Ebola virus (EBOV) VP40 regulates viral budding, nucleocapsid recruitment, virus structure and stability, viral genome replication and transcription, and has an intrinsic ability to form virus-like particles. The elucidation of the regulation of VP40 functions is essential to i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baz-Martínez, Maite, El Motiam, Ahmed, Ruibal, Paula, Condezo, Gabriela N., de la Cruz-Herrera, Carlos F., Lang, Valerie, Collado, Manuel, San Martín, Carmen, Rodríguez, Manuel S., Muñoz-Fontela, Cesar, Rivas, Carmen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110971/ https://www.ncbi.nlm.nih.gov/pubmed/27849047 http://dx.doi.org/10.1038/srep37258

Ejemplares similares

Phosphorylable tyrosine residue 162 in the double-stranded RNA-dependent kinase PKR modulates its interaction with SUMO
por: de la Cruz-Herrera, Carlos F., et al.
Publicado: (2017)

Expression of the Ebola Virus VP24 Protein Compromises the Integrity of the Nuclear Envelope and Induces a Laminopathy-Like Cellular Phenotype
por: Vidal, Santiago, et al.
Publicado: (2021)

Cell senescence is an antiviral defense mechanism
por: Baz-Martínez, Maite, et al.
Publicado: (2016)

A cylindrical assembly model and dynamics of the Ebola virus VP40 structural matrix
por: Pavadai, Elumalai, et al.
Publicado: (2018)

Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers
por: Wan, William, et al.
Publicado: (2020)

SUMO and Cytoplasmic RNA Viruses: From Enemies to Best Friends
por: El Motiam, Ahmed, et al.
Publicado: (2019)

High-throughput virtual screening and docking studies of matrix protein vp40 of ebola virus
por: Tamilvanan, Thangaraju, et al.
Publicado: (2013)

The Ebola virus VP40 matrix layer undergoes endosomal disassembly essential for membrane fusion
por: Winter, Sophie L, et al.
Publicado: (2023)

Membrane binding and bending in Ebola VP40 assembly and egress
por: Stahelin, Robert V.
Publicado: (2014)

Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology
por: Johnson, Reed F, et al.
Publicado: (2006)

Structural studies on the Ebola virus matrix protein VP40 indicate that matrix proteins of enveloped RNA viruses are analogues but not homologues
por: Timmins, Joanna, et al.
Publicado: (2004)

Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
por: Pleet, Michelle L., et al.
Publicado: (2016)

Cheminformatics-Based Study Identifies Potential Ebola VP40 Inhibitors
por: Broni, Emmanuel, et al.
Publicado: (2023)

Identification of Continuous Human B-Cell Epitopes in the VP35, VP40, Nucleoprotein and Glycoprotein of Ebola Virus
por: Becquart, Pierre, et al.
Publicado: (2014)

Integrated Computational Approach for Virtual Hit Identification against Ebola Viral Proteins VP35 and VP40
por: Mirza, Muhammad Usman, et al.
Publicado: (2016)

Assembly of Ebola Virus Matrix Protein VP40 Is Regulated by Latch-Like Properties of N and C Terminal Tails
por: Silva, Leslie P., et al.
Publicado: (2012)

The Matrix Protein VP40 from Ebola Virus Octamerizes into Pore-like Structures with Specific RNA Binding Properties
por: Gomis-Rüth, F.Xavier, et al.
Publicado: (2003)

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures
por: Bennett, Ryan P., et al.
Publicado: (2020)

Corrigendum: Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
por: Pleet, Michelle L., et al.
Publicado: (2018)

Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles
por: Pleet, Michelle L, et al.
Publicado: (2018)

Analysis of SUMOylated proteins using SUMO-traps
por: Da Silva-Ferrada, Elisa, et al.
Publicado: (2013)

Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essential regulatory form
por: Landeras-Bueno, Sara, et al.
Publicado: (2021)

Molecular docking based screening of compounds against VP40 from Ebola virus
por: M Alam El-Din, Hanaa, et al.
Publicado: (2016)

Editorial: SUMO Proteins in Host Defense
por: Rivas, Carmen
Publicado: (2021)

Evaluation of Fendiline Treatment in VP40 System with Nucleation-Elongation Process: A Computational Model of Ebola Virus Matrix Protein Assembly
por: Liu, Xiao, et al.
Publicado: (2023)

Molecular docking based screening of predicted potential inhibitors for VP40 from Ebola virus
por: Abazari, Danya, et al.
Publicado: (2015)

Molecular docking enabled updated screening of the matrix protein VP40 from Ebola virus with millions of compounds in the MCULE database for potential inhibitors
por: Odhar, Hasanain Abdulhameed, et al.
Publicado: (2019)

Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress
por: Liang, Jingjing, et al.
Publicado: (2017)

Ebola Virus Disease in Humans: Pathophysiology and Immunity
por: Muñoz-Fontela, César, et al.
Publicado: (2017)

The Minor Matrix Protein VP24 from Ebola Virus Lacks Direct Lipid-Binding Properties
por: Su, Yuan, et al.
Publicado: (2020)

A Loop Region in the N-Terminal Domain of Ebola Virus VP40 Is Important in Viral Assembly, Budding, and Egress
por: Adu-Gyamfi, Emmanuel, et al.
Publicado: (2014)

Correction: Chaperone-Mediated Autophagy Protein BAG3 Negatively Regulates Ebola and Marburg VP40-Mediated Egress
por: Liang, Jingjing, et al.
Publicado: (2017)

Ubiquitin Ligase SMURF2 Interacts with Filovirus VP40 and Promotes Egress of VP40 VLPs
por: Shepley-McTaggart, Ariel, et al.
Publicado: (2021)

The Ebola Virus matrix protein, VP40, requires phosphatidylinositol 4,5-bisphosphate (PI(4,5)P(2)) for extensive oligomerization at the plasma membrane and viral egress
por: Johnson, Kristen A., et al.
Publicado: (2016)

Comparative pathogenesis of Ebola virus and Reston virus infection in humanized mice
por: Escudero-Pérez, Beatriz, et al.
Publicado: (2019)

Quantification of Type I Interferon Inhibition by Viral Proteins: Ebola Virus as a Case Study
por: Locke, Macauley, et al.
Publicado: (2021)

Alphavirus Replicon DNA Vectors Expressing Ebola GP and VP40 Antigens Induce Humoral and Cellular Immune Responses in Mice
por: Ren, Shoufeng, et al.
Publicado: (2018)

Protein Folding Interdiction Strategy for Therapeutic Drug Development in Viral Diseases: Ebola VP40 and Influenza A M1
por: Bergasa-Caceres, Fernando, et al.
Publicado: (2022)

Ebola virus protein VP40 stimulates IL-12– and IL-18–dependent activation of human natural killer cells
por: Le, Hung, et al.
Publicado: (2022)

Localization of adenovirus morphogenesis players, together with visualization of assembly intermediates and failed products, favor a model where assembly and packaging occur concurrently at the periphery of the replication center
por: Condezo, Gabriela N., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_j79n32atgfm10k4liaboga7bmk